Personas / Equipo Humano

Begoña Nafria Escalera

Buscador de publicaciones

Publicaciones

  • Bray L, Carter B, Blake L, Saron H, Kirton JA, Robichaud F, Avila M, Ford K, Nafria-Escalera B, Forsner M, Nilsson S, Chelkowski A, Middleton A, Rullander AC, Mattsson J and Protheroe J.

    "People play it down and tell me it can't kill people, but I know people are dying each day". Children's health literacy relating to a global pandemic (COVID-19); an international cross sectional study.

    PLoS One . 16(2): . Nº de citas: 41

    [doi:10.1371/journal.pone.0246405]

  • Tsang VWL, West L, Woods C, Koh CJ, McCune S, Mullin T, Smith SR, Gaillard S, Claverol J, Nafria-Escalera B, Preston J, Dicks P and Thompson C.

    Role of Patients and Parents in Pediatric Drug Development

    Therapeutic Innovation & Regulatory Science . 53(5): 601-608. Nº de citas: 17

    [doi:10.1177/2168479018820875]

  • Nordenmalm S, Kimland E, Ligas F, Lehmann B, Claverol J, Nafria-Escalera B, Tötterman AM and Pelle B.

    Children's views on taking medicines and participating in clinical trials

    ARCHIVES OF DISEASE IN CHILDHOOD . 104(9): 900-905. Nº de citas: 14

    [doi:10.1136/archdischild-2018-316511]

  • Badia X, Aguarón A, Fernández A, Gimón A, Nafria-Escalera B, Gaspar B, Guarga L, Gálvez M, Fuentes M, Paco N and Saldaña R.

    Patient involvement in reflective multicriteria decision analysis to assist decision making in oncology

    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE . 35(1): 56-63. Nº de citas: 17

    [doi:10.1017/S0266462318003641]

  • Deane K, Delbecque L, Gorbenko O, Hamoir AM, Hoos A, Nafria-Escalera B, Pakarinen C, Sargeant I, Richards DP, Skovlund SE and Brooke N.

    Co-creation of patient engagement quality guidance for medicines development: an international multistakeholder initiative.

    BMJ Innovations . 5(1): 43-55.

    [doi:10.1136/bmjinnov-2018-000317]

  • Gaillard S, Malik S, Preston J, Nafria-Escalera B, Dicks P, Touil N, Mardirossian S, Claverol J and Kassai B.

    Involving children and young people in clinical research through the forum of a European Young Persons' Advisory Group: needs and challenges.

    FUNDAMENTAL & CLINICAL PHARMACOLOGY . 32(4): 357-362. Nº de citas: 46

    [doi:10.1111/fcp.12360]

  • Nafria-Escalera B, Claverol J, Cubells M, Llanos C, Solé L, Sans E, López S, Català-Mora J, Rives-Solà S, Morales-La Madrid A, Pineda M, Garcia-Cazorla A, Nascimento-Osorio A, Morales-Ballús M, Roe D, Fortuny-Guasch C and Phillips B.

    Cross-border access to clinical trials: participation of pediatric patients and language inclusion.

    PEDIATRIC RESEARCH . : .

    [doi:10.1038/s41390-026-04820-z]

  • Baba A, Smith M, Potter BK, Chan AW, Moher D, Toulany A, Doherty-Kirby A, Nafria-Escalera B, Stratton C, Gale C, Macarthur C, Purper-Ouakil D, Juszczak E, Cohen E, Reggiardo G, Preston J, Cohen E, Upton J, Allegaert K, Boerner K and Offringa M.

    CONSORT-Children and Adolescents (CONSORT-C) 2026 extension statement: enhancing the reporting and impact of paediatric randomised trials

    Lancet Child & Adolescent Health . : . Nº de citas: 3

    [doi:10.1016/S2352-4642(26)00004-0]

  • Baba A, Smith M, Potter BK, Chan AW, Moher D, Toulany A, Doherty-Kirby A, Nafria-Escalera B, Stratton C and Ofringa M.

    SPIRIT-Children and Adolescents (SPIRIT-C) 2026 extension statement: enhancing the reporting and usefulness of paediatric randomised trial protocols

    Lancet Child & Adolescent Health . : . Nº de citas: 3

    [doi:10.1016/S2352-4642(26)00005-2]

  • Nafria-Escalera B, Gaillard S, Dehlinger-Kremer M, Dicks P, Fernandes R, Bray L, Bierer BE and Phillips B.

    Parents' Perspectives on Access to Pediatric Rare Disease Cross-Border Clinical Trials in Europe: Experiences of Language Inclusion and Preferences.

    Therapeutic Innovation & Regulatory Science . : .

    [doi:10.1007/s43441-026-00942-y]